GYNECOLOGY

FRIDAY, DECEMBER 3

08:30-10:00 HRT AND CANCER HALL B
Capsule Demystification of the  relationship between HRT and cancer
Chairpersons Santiago Palacios, Spain
Sven O. Skouby, Denmark
08:30-09:00 Can HRT and treatment for menopause be individualized to reduce the incidence of breast cancer?
Mark Brincat, Malta   
09:00-09:30 Breast cancer in special populations
Herjan Coelingh Bennink, Netherlands
09:30-10:00 HRT in cancer survivors
Pierluigi Benedetti Panici, Italy

 

10:00-10:20 Coffee break,  poster viewing and visit the exhibition Exhibition Area

 

10:20-11:50 INDUSTRY SUPPORTED SESSION HALL B

 

11:50-12:10 Break

 

12:10-13:40 VULVAR AND VAGINA HALL B
Capsule Longevity accentuates the need for better strategies for vulvar and vaginal atrophy
Chairperson Nick Panay, UK
Sven O. Skouby, Denmark
12:10-12:30 Advances in anatomy and physiology of the vagina based on new treatments
Santiago Palacios, Spain
12:30-12:50 Vulvar pains and co-morbidities: Data from 1183 cases
Alessandra Graziottin, Italy
Capsule Postmenopausal atrophy of the lower genital and urinary tract is distressing and requires new ideas to control symptoms
12:50-13:20

12:50
13:00
13:10

 Debate: Is laser effective for treatment of Stress Urinary Incontinence (SUI)

Yes: Zdenko Vizintin, Slovenia
No: Tim Hillard, UK
Discussion
13:20-13:40 Translational medicine in reproductive ageing
Sven O. Skouby, Denmark

 

13:40-14:30  Lunch break,  poster viewing and visit the exhibition Exhibition Area

 

14:30-16:30 PRESCRIBING HRT HALL B
Capsule Balancing the benefits/risks of HRT will allow larger populations to enjoy HRT
Chairpersons Mark Brincat, Malta
Alessandra Graziottin, Italy
Capsule The controversy surrounding androgen addition to HRT is ongoing
14:30-15:00 Should androgens be routinely offered to optimize quality of life in menopause?
Alessandra Graziottin, Italy
15:00-15:30 Update on practical prescribing of new hormone therapy regimens
Nick Panay, UK
15:30-16:00 New strategies in the prevention of fragility fractures
Santiago Palacios, Spain
16:00-16:30 Use of HRT for cardiovascular prevention
Johannes Ott, Austria

 

16:30-16:50  Coffee break,  poster viewing and visit the exhibition Exhibition Area

 

16:50-18:20 GLOBAL HEALTH INITIATIVES IN GYNECOLOGICAL MALIGNANCIES HALL B
Capsule In 90 minutes around the world
Chairpersons Sara Nasser, Germany
Jalid Sehouli, Germany
16:50-16:55 Greetings and Introduction
1655-17:05 A wake-up call: Gynecological oncology on the global health agenda
Andreas Ullrich, Switzerland
17:05-17:15 20 years of gynaecological capacity building in Cameroon through partnership
Patrick Petignant, Switzerland
17:15-1720 Q & A
17:20-17:30 Digital health as a driver for global women’s health: The iSTARC and PARSGO Vision
Sara Nasser, Germany
17:30-17:40 Patient advocacy groups in the MENA Region
Joelle Abou Khalil, Lebanon-Sweden
17:40-17:50 Q & A
17:50-18:00 Towards a global women’s health taskforce
Jalid Sehouli, Germany
18:00-18:20 Panel Discussion:
Namory Keita, Guinea
Basel Refky, Egypt
Hind ElMalik,  Qatar

 

SATURDAY, DECEMBER 4

08:30-10:00 ENDOMETRIAL CANCER HALL B
Capsule News, options and current barriers in the management of endometrial cancer
Chairpersons Robert Armbrust, Germany
Jalid Sehouli, Germany
08:30-09:00 Clinical implications of molecular diagnostics in endometrial cancer
Elena Braicu, Germany
09:00-09:30 Personalized surgical approach in endometrial cancer
Robert Armbrust, Germany
09:30-10:00 New options in medical therapy of advanced and relapsed endometrial cancer
Jalid Sehouli, Germany

 

10:00-10:20  Coffee break,  poster viewing and visit the exhibition Exhibition Area

 

10:20-11:50 WOMEN’S HEALTH AND WEALTH
A PREIS SCHOOL ACADEMY SESSION		 HALL B
Chairpersons Gian Carlo Di Renzo, Italy
Nick Panay,UK
10:20-10:25 Welcome
Gian Carlo Di Renzo, Italy
10:25-10:35 The Welfare of Women (WoW) global health program endorsed by FIGO
Gian Carlo Di Renzo, Italy
10:35-10:50 Will body-identical MHT become the first choice for menopausal hormone therapy?
Vanadin Seifert-Klauss, Germany
10:50-11:05 Testosterone or not testosterone in menopause: That’s the question!
Nick Panay, UK
11:05-11:20 Which progestogen to optimize breast and endometrial safety in MHT?
Ewald Boschitsch, Austria
11:20-11:50 Q & A

 

11:50-12:00 Break

 

12:00-13:30 IN SEARCH OF NEW PERSPECTIVES: POI MAINLY DRIVEN BY GENETICS HALL B
Capsule Can better understanding lead to better solutions?
Chairpersons Bart Fauser, Netherlands
Nick Panay, UK
12:00-12:25 Is the ovary the mirror of longevity?
Micheline Misrahi, France
12:25-12:45 Genetic architecture of reproductive ageing
Felix Day, UK
12:45-13:05 FMR1 and the genetic control of folliculogenesis
Julia Rehnitz, Germany
13:05-13:30 Endo-ERN and POI
Luca Persani, Italy

 

13:30-14:20 Lunch break,  poster viewing and visit the exhibition Exhibition Area

 

14:20-15:50 SLS: THE SOCIETY OF LAPAROENDOSCOPIC SURGEONS HALL B
Capsule Surgical management of endometriosis depends on thorough understanding of the pathophysiology and anatomy
Chairpersons Jessica Ybanez Morano, USA
Mona Orady, USA
14:20-14:50 VNOTES: Vaginal Natural Orifice Transluminal Endoscopic Surgery
Jessica Ybanez Morano, USA
14:50-15:20 Pearls in endometrioma management
Mona Orady, USA
15:20-15:50 Robotics: A systematic approach to deep infiltrative endometriosis
Thiers Soares Raymundo, Brazil

 

15:50-16:00 Break

 

16:00-17:00 INDUSTRY SUPPORTED SESSION HALL B